Nautilus Biotechnology Initiated at Buy by Roth Capital
Ratings actions from Benzinga: GMT) Nautilus Biotechnology Price Target Announced at $3.50/Share by Roth CapitalRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Nautilus Biotechnology Price Target Announced at $3.50/Share by Roth CapitalRatings actions from Benzinga